Recruiting studies: Stage Ii Testicular Seminoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

MicroRNA as Markers in Testicular Cancer
Phase N/A · 6 location(s) · Haukeland University Hospital · NCT04914026 Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring
Phase 2 · 3 location(s) · Centre Oscar Lambret · NCT05500391 A Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retr
Phase 2 · 1 location(s) · Western University, Canada · NCT06932458 De-escalation Study for Stage IIa/IIb < 3 cm Seminoma
Phase 2 · 15 location(s) · Centre Leon Berard · NCT05529251 Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ C
Phase 3 · 629 location(s) · Children's Oncology Group · NCT03067181 R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma
NA · 1 location(s) · University Health Network, Toronto · NCT05345158 Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III
Phase 1 · 1 location(s) · City of Hope Medical Center · NCT07218913 PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLND
Phase 2 · 1 location(s) · Heinrich-Heine University, Duesseldorf · NCT06144736

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.